Ispire Q3 FY2025 revenue down 12.7% to $26.2M, net loss widens to $10.9M

Ispire Technology Inc.

2025-Q3 EPS reported -$0.43 vs consensus -$0.10 ▼ miss (-321.6%)

Revenue $26.2M vs $30.0M in prior-year quarter (down 12.7%); net loss $10.9M ($0.19/sh) vs $5.9M ($0.11/sh).
Gross margin fell to 18.2% from 20.4% on unfavorable product mix; accounts receivable reduced to $60.4M from $67.7M.
Operating expenses rose to $15.4M from $11.8M, driven by restructuring and Malaysia campus transition.
IKE Tech joint venture filed component PMTA with FDA for blockchain age-gating tech; Malaysia nicotine manufacturing interim license received.
Launched Sprout all-in-one cannabis vapor device with Raw Garden.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.